These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Reappraisal of spontaneous stereotypy in the deer mouse as an animal model of obsessive-compulsive disorder (OCD): response to escitalopram treatment and basal serotonin transporter (SERT) density. Wolmarans de W; Brand L; Stein DJ; Harvey BH Behav Brain Res; 2013 Nov; 256():545-53. PubMed ID: 24013013 [TBL] [Abstract][Full Text] [Related]
24. Assessment and management of treatment-refractory obsessive-compulsive disorder in children. Bloch MH; Storch EA J Am Acad Child Adolesc Psychiatry; 2015 Apr; 54(4):251-62. PubMed ID: 25791142 [TBL] [Abstract][Full Text] [Related]
26. A review of the efficacy of selective serotonin reuptake inhibitors in obsessive-compulsive disorder. Pigott TA; Seay SM J Clin Psychiatry; 1999 Feb; 60(2):101-6. PubMed ID: 10084636 [TBL] [Abstract][Full Text] [Related]
27. Behavioral therapy and serotonin reuptake inhibitor pharmacotherapy in the treatment of obsessive-compulsive disorder: a systematic review and meta-analysis of head-to-head randomized controlled trials. Romanelli RJ; Wu FM; Gamba R; Mojtabai R; Segal JB Depress Anxiety; 2014 Aug; 31(8):641-52. PubMed ID: 24390912 [TBL] [Abstract][Full Text] [Related]
28. Obsessive-compulsive disorder: implications of the efficacy of an SSRI, paroxetine. Ninan PT Psychopharmacol Bull; 2003; 37 Suppl 1():89-96. PubMed ID: 14566204 [TBL] [Abstract][Full Text] [Related]
29. Memantine augmentation of sertraline in the treatment of symptoms and executive function among patients with obsessive-compulsive disorder: A double-blind placebo-controlled, randomized clinical trial. Askari S; Mokhtari S; Shariat SV; Shariati B; Yarahmadi M; Shalbafan M BMC Psychiatry; 2022 Jan; 22(1):34. PubMed ID: 35022014 [TBL] [Abstract][Full Text] [Related]
30. [Is it time for revision of the section on obsessive-compulsive disorder in the Guideline on Anxiety Disorders?]. van Ingen Schenau WJ; Wisman PW Tijdschr Psychiatr; 2007; 49(5):315-25. PubMed ID: 17492582 [TBL] [Abstract][Full Text] [Related]
31. Risperidone and haloperidol augmentation of serotonin reuptake inhibitors in refractory obsessive-compulsive disorder: a crossover study. Li X; May RS; Tolbert LC; Jackson WT; Flournoy JM; Baxter LR J Clin Psychiatry; 2005 Jun; 66(6):736-43. PubMed ID: 15960567 [TBL] [Abstract][Full Text] [Related]
32. Transcutaneous electrical acupoint stimulation as an adjunct therapy for obsessive-compulsive disorder: A randomized controlled study. Feng B; Zhang ZJ; Zhu RM; Yuan GZ; Luo LY; McAlonan GM; Xu FZ; Chen J; Liu LY; Lv YY; Wong HK; Zhang Y; Zhu LX J Psychiatr Res; 2016 Sep; 80():30-37. PubMed ID: 27281260 [TBL] [Abstract][Full Text] [Related]
33. Use of factor-analyzed symptom dimensions to predict outcome with serotonin reuptake inhibitors and placebo in the treatment of obsessive-compulsive disorder. Mataix-Cols D; Rauch SL; Manzo PA; Jenike MA; Baer L Am J Psychiatry; 1999 Sep; 156(9):1409-16. PubMed ID: 10484953 [TBL] [Abstract][Full Text] [Related]
34. [Obsessive-compulsive disorder (OCD) in childhood]. Puustjärvi A; Asikainen M Duodecim; 2010; 126(24):2855-63. PubMed ID: 21268908 [TBL] [Abstract][Full Text] [Related]
36. Obsessive-compulsive disorder presenting with musical obsessions in otosclerosis: a case report. Islam L; Scarone S; Gambini O J Med Case Rep; 2014 Nov; 8():384. PubMed ID: 25418908 [TBL] [Abstract][Full Text] [Related]
38. Challenges in treating obsessive-compulsive disorder: introduction. Wilhelm S; Tolin DF; Steketee G J Clin Psychol; 2004 Nov; 60(11):1127-32. PubMed ID: 15389623 [TBL] [Abstract][Full Text] [Related]
39. Diagnosis and treatment of obsessive-compulsive disorder and related disorders. Dell'Osso B; Altamura AC; Mundo E; Marazziti D; Hollander E Int J Clin Pract; 2007 Jan; 61(1):98-104. PubMed ID: 17229184 [TBL] [Abstract][Full Text] [Related]